Literature DB >> 32748494

Blood pressure, antihypertensive medication and neuropsychiatric symptoms in older people with dementia: The COSMOS study.

Bianca E M de Jong-Schmit1, Rosalinde K E Poortvliet1, Stefan Böhringer2, Jonathan M K Bogaerts1, Wilco P Achterberg1, Bettina S Husebo3.   

Abstract

OBJECTIVES: Neuropsychiatric symptoms (NPS) are very common in older patients with dementia. There is increasing evidence that hypoperfusion of the brain plays a role in the development of NPS. The aim of this study is to assess whether there is an association between low systolic blood pressure (SBP) and NPS and if NPS are more prevalent in older people with dementia using antihypertensive medication.
METHODS: We studied the baseline data from participants in the Communication, Systematic pain treatment, Medication review, Organized activities and Safety study, a multicenter clustered trial with 765 participants from 72 nursing home units from 37 nursing homes in Norway. SBP (lowest quartile vs rest) and use of antihypertensive medication were predictors and Neuropsychiatric Inventory-Nursing Home version (NPI-NH) score (total and clusters) was the outcome. Missing data were imputed, except for missing data in predictors. We used a mixed model analysis adjusted for age, sex and Minimal Mental State Examination (MMSE) score. In a sensitivity analysis, continuous SBP values were used.
RESULTS: In total, 412 patients were included with a mean age of 86.9 years, 53.9% had a MMSE score of <11. There was no difference in total NPI-NH score between low and high SBP (difference -1.07, Pdj = 0.62). There was no difference between high and low SBP and the NPI clusters. The use of antihypertensive medication was not associated with a different total or cluster NPI-NH score compared to no use (difference -0.99, Padj = 0.95, Pall = 0.37-0.99, respectively). In the sensitivity analyses with the continuous SBP levels, there was no association between SBP and NPI-NH score (estimate 1.00, 95%CI 0.98-1.01, P = 0.25).
CONCLUSION: We found no association between low SBP and NPS, nor between antihypertensive use and NPS.
© 2020 The Authors. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.

Entities:  

Keywords:  antihypertensive medication; blood pressure; dementia; neuropsychiatric symptoms

Year:  2020        PMID: 32748494      PMCID: PMC7756813          DOI: 10.1002/gps.5388

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  38 in total

Review 1.  Treatment of hypertension: The ESH/ESC guidelines recommendations.

Authors:  Cesare Cuspidi; Marijana Tadic; Guido Grassi; Giuseppe Mancia
Journal:  Pharmacol Res       Date:  2017-10-27       Impact factor: 7.658

Review 2.  An Expert Opinion From the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old, Frail Subjects.

Authors:  Athanase Benetos; Christopher J Bulpitt; Mirko Petrovic; Andrea Ungar; Enrico Agabiti Rosei; Antonio Cherubini; Josep Redon; Tomasz Grodzicki; Anna Dominiczak; Timo Strandberg; Giuseppe Mancia
Journal:  Hypertension       Date:  2016-03-14       Impact factor: 10.190

3.  Cerebral blood flow correlates of apathy in Alzheimer disease.

Authors:  A H Craig; J L Cummings; L Fairbanks; L Itti; B L Miller; J Li; I Mena
Journal:  Arch Neurol       Date:  1996-11

4.  Left frontotemporal hypoperfusion is associated with aggression in patients with dementia.

Authors:  N Hirono; M S Mega; I D Dinov; F Mishkin; J L Cummings
Journal:  Arch Neurol       Date:  2000-06

5.  Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

Authors:  Constantine G Lyketsos; Oscar Lopez; Beverly Jones; Annette L Fitzpatrick; John Breitner; Steven DeKosky
Journal:  JAMA       Date:  2002-09-25       Impact factor: 56.272

6.  The impact of antipsychotics and neuropsychiatric symptoms on the quality of life of people with dementia living in nursing homes.

Authors:  Julia van de Ven-Vakhteeva; Hans Bor; Roland B Wetzels; Raymond T C M Koopmans; Sytse U Zuidema
Journal:  Int J Geriatr Psychiatry       Date:  2012-08-07       Impact factor: 3.485

7.  The reliability and validity of the Norwegian version of the Neuropsychiatric Inventory, nursing home version (NPI-NH).

Authors:  Geir Selbaek; Oyvind Kirkevold; Oskar H Sommer; Knut Engedal
Journal:  Int Psychogeriatr       Date:  2007-06-11       Impact factor: 3.878

8.  Mapping scores onto stages: mini-mental state examination and clinical dementia rating.

Authors:  Robert Perneczky; Stefan Wagenpfeil; Katja Komossa; Timo Grimmer; Janine Diehl; Alexander Kurz
Journal:  Am J Geriatr Psychiatry       Date:  2006-02       Impact factor: 4.105

9.  Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study.

Authors:  Martin Steinberg; Huibo Shao; Peter Zandi; Constantine G Lyketsos; Kathleen A Welsh-Bohmer; Maria C Norton; John C S Breitner; David C Steffens; Joann T Tschanz
Journal:  Int J Geriatr Psychiatry       Date:  2008-02       Impact factor: 3.485

10.  Brain Perfusion Correlates of Apathy in Alzheimer's Disease.

Authors:  Hyeonseok Jeong; Ilhyang Kang; Jooyeon J Im; Jong-Sik Park; Seung-Hee Na; Youngje Heo; YoungSoon Yang; Yong-An Chung; In-Uk Song
Journal:  Dement Neurocogn Disord       Date:  2018-07-20
View more
  3 in total

1.  The longitudinal association between the use of antihypertensive medications and 24-hour sleep in nursing homes: results from the randomized controlled COSMOS trial.

Authors:  Elisabeth Flo-Groeneboom; Tony Elvegaard; Christine Gulla; Bettina S Husebo
Journal:  BMC Geriatr       Date:  2021-07-18       Impact factor: 3.921

2.  Blood pressure, antihypertensive medication and neuropsychiatric symptoms in older people with dementia: The COSMOS study.

Authors:  Bianca E M de Jong-Schmit; Rosalinde K E Poortvliet; Stefan Böhringer; Jonathan M K Bogaerts; Wilco P Achterberg; Bettina S Husebo
Journal:  Int J Geriatr Psychiatry       Date:  2020-10-08       Impact factor: 3.485

Review 3.  Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?

Authors:  Chul-Kyu Kim; Perminder S Sachdev; Nady Braidy
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.